Named on 2 rounds in the feed.
Rounds from ~ 2019-12-12 to 2020-04-01
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Aspen Neuroscience Aspen Neuroscience develops personalized regenerative therapies, specifically autologous iPSC-derived cell replacement therapies for Parkinson's disease. | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $70M | 2020-04-01 | [ PART ] |
Aspen Neuroscience Aspen Neuroscience develops personalized regenerative therapies, specifically autologous iPSC-derived cell replacement therapies for Parkinson's disease. | Seed Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6.5M | ~ 2019-12-12 | [ LEAD ] |
No sector on record.